In both emerging and developed countries, the introduction of novel infections and the re-emergence of existing diseases have produced substantial domestic and public health problems. In addition, infectious diseases account for the majority of disability-adjusted life years and the global mortality rate.
Furthermore, rising antimicrobial resistance has sparked global concern about superinfection, making it difficult to combat prospective diseases. As a result, infectious diseases are receiving increased attention in the twenty-first century. It constitutes a crucial action agenda for global health leaders, healthcare professionals, policymakers, and researchers. Scientists are working to develop new antibiotics, therapy regimens, and vaccines to combat current and future illnesses.
